| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |